{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:09:52Z","timestamp":1776168592958,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2304600"],"award-info":[{"award-number":["2022YFC2304600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2023-PT320-01"],"award-info":[{"award-number":["2023-PT320-01"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.virs.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:12:09Z","timestamp":1769616729000},"page":"84-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of humoral and T-cell immune responses in people living with HIV after breakthrough SARS-CoV-2 Omicron variant infection during December 2022 to January 2023"],"prefix":"10.1016","volume":"41","author":[{"given":"Hai-Bo","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Hui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Hai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Qing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Chun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Li","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Lu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Qing","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3545-3758","authenticated-orcid":false,"given":"Tao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1427-8428","authenticated-orcid":false,"given":"Xiao-Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-8943","authenticated-orcid":false,"given":"Hong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2026.01.003_bib1","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1038\/s41467-021-26137-7","article-title":"Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV","volume":"12","author":"Alrubayyi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.01.003_bib2","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1093\/cid\/ciac238","volume":"75","author":"Antinori","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virs.2026.01.003_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.01.003_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.01.003_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/QAD.0000000000003504","article-title":"Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people with HIV","volume":"37","author":"Casado","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.virs.2026.01.003_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1473-3099(23)00058-0","article-title":"Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study","volume":"23","author":"Chemaitelly","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2026.01.003_bib7","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.7150\/ijbs.73583","article-title":"Humoral and cellular immune responses of COVID-19 vaccines against SARS-Cov-2 omicron variant: a systemic review","volume":"18","author":"Chen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.virs.2026.01.003_bib8","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.cmi.2022.05.018","article-title":"Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV","volume":"28","author":"Corma-G\u00f3mez","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.virs.2026.01.003_bib9","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.01.003_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","article-title":"SARS-CoV-2 omicron variant: recent progress and future perspectives","volume":"7","author":"Fan","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virs.2026.01.003_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2451","article-title":"Humoral immune response to two doses of COVID-19 mRNA-based vaccines in people living with HIV: a systematic review and meta-analysis","volume":"33","author":"Farhadian","year":"2023","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virs.2026.01.003_bib12","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2352-3018(21)00103-X","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2\/3 clinical trial","volume":"8","author":"Frater","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.virs.2026.01.003_bib13","doi-asserted-by":"crossref","first-page":"101360","DOI":"10.1016\/j.eclinm.2022.101360","article-title":"Sputnik V protection from COVID-19 in people living with HIV under antiretroviral therapy","volume":"46","author":"Gushchin","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.virs.2026.01.003_bib14","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0000000000003166","article-title":"Impaired antibody response to COVID-19 vaccination in advanced HIV infection","volume":"36","author":"Hassold","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.virs.2026.01.003_bib15","doi-asserted-by":"crossref","first-page":"104661","DOI":"10.1016\/j.ebiom.2023.104661","article-title":"Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort study","volume":"93","author":"Heftdal","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virs.2026.01.003_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003979","article-title":"Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: a nationwide prospective cohort study","volume":"19","author":"Hensley","year":"2022","journal-title":"PLoS Med."},{"key":"10.1016\/j.virs.2026.01.003_bib17","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41590-023-01449-6","article-title":"Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants","volume":"24","author":"Ju","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virs.2026.01.003_bib18","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1038\/s41467-021-24377-1","article-title":"SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells","volume":"12","author":"Jung","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.01.003_bib19","doi-asserted-by":"crossref","first-page":"100898","DOI":"10.1016\/j.xcrm.2022.100898","article-title":"Impact of SARS-CoV-2 exposure history on the T cell and IgG response","volume":"4","author":"Keeton","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.virs.2026.01.003_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/pathogens12020169","article-title":"First impressions matter: immune imprinting and antibody cross-reactivity in influenza and SARS-CoV-2","volume":"12","author":"King","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.virs.2026.01.003_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41591-023-02212-y","article-title":"Estimating the transmission dynamics of SARS-CoV-2 omicron BF.7 in beijing after adjustment of the zero-COVID policy in November-December 2022","volume":"29","author":"Leung","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2026.01.003_bib22","doi-asserted-by":"crossref","first-page":"100287","DOI":"10.1016\/j.lanepe.2021.100287","article-title":"Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study","volume":"13","author":"Lombardi","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.virs.2026.01.003_bib23","doi-asserted-by":"crossref","first-page":"100679","DOI":"10.1016\/j.xcrm.2022.100679","article-title":"Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 omicron variant","volume":"3","author":"Lyke","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.virs.2026.01.003_bib24","doi-asserted-by":"crossref","first-page":"1136723","DOI":"10.3389\/fimmu.2023.1136723","article-title":"Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: the COVIH-DAPT study","volume":"14","author":"Manni","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.01.003_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/978-1-4684-0943-7_24","article-title":"Interactions of keratins with metal ions: uptake profiles, mode of binding, and effects on properties of wool","volume":"48","author":"Masri","year":"1974","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.virs.2026.01.003_bib26","doi-asserted-by":"crossref","first-page":"eabj9853","DOI":"10.1126\/science.abj9853","article-title":"Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells","volume":"374","author":"Mateus","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.01.003_bib27","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2352-3018(22)00033-9","article-title":"Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study","volume":"9","author":"Netto","year":"2022","journal-title":"Lancet HIV"},{"key":"10.1016\/j.virs.2026.01.003_bib28","doi-asserted-by":"crossref","first-page":"1291048","DOI":"10.3389\/fimmu.2023.1291048","article-title":"Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV","volume":"14","author":"Ng'uni","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.01.003_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78374","article-title":"Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition","volume":"11","author":"Nkosi","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.virs.2026.01.003_bib30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s15010-021-01721-7","article-title":"Humoral response to SARS-CoV-2 vaccines in people living with HIV","volume":"50","author":"Noe","year":"2022","journal-title":"Infection"},{"key":"10.1016\/j.virs.2026.01.003_bib31","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1016\/S2352-3018(21)00240-X","article-title":"Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study","volume":"8","author":"Nomah","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.virs.2026.01.003_bib32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(23)00129-0","article-title":"Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis","volume":"401","author":"Pan","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.01.003_bib33","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3390\/vaccines10122129","article-title":"Immune responses against the omicron variant of SARS-CoV-2 after a third dose of COVID-19 vaccine in patients living with human immunodeficiency virus (PLWH): Comparison with healthcare workers","volume":"10","author":"Park","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virs.2026.01.003_bib34","doi-asserted-by":"crossref","first-page":"F7","DOI":"10.1097\/QAD.0000000000003338","article-title":"Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection","volume":"36","author":"Peluso","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.virs.2026.01.003_bib35","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virs.2026.01.003_bib36","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41467-023-36250-4","article-title":"SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection","volume":"14","author":"Pu\u0161nik","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.01.003_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149125","article-title":"Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection","volume":"131","author":"Riou","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.virs.2026.01.003_bib38","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1097\/QAD.0000000000002945","article-title":"Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIV","volume":"35","author":"Ruddy","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.virs.2026.01.003_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158402","article-title":"Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19","volume":"7","author":"Schuster","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.virs.2026.01.003_bib40","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1093\/cid\/ciab758","article-title":"Similar antibody responses against severe acute respiratory syndrome Coronavirus 2 in individuals living without and with human immunodeficiency virus on antiretroviral therapy during the first South African infection wave","volume":"75","author":"Snyman","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virs.2026.01.003_bib41","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S2352-3018(21)00072-2","article-title":"SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study","volume":"8","author":"Spinelli","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.virs.2026.01.003_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/QAD.0000000000003492","article-title":"Effectiveness of COVID-19 primary and booster vaccination in HIV-Infected individuals","volume":"37","author":"Su","year":"2023","journal-title":"Aids"},{"key":"10.1016\/j.virs.2026.01.003_bib43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","article-title":"Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations","volume":"21","author":"Tao","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.virs.2026.01.003_bib44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2026.01.003_bib45","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/infdis\/jiab616","article-title":"Similar risk of severe acute respiratory syndrome coronavirus 2 infection and similar nucleocapsid antibody levels in people with well-controlled Human Immunodeficiency Virus (HIV) and a comparable cohort of people without HIV","volume":"225","author":"Verburgh","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.01.003_bib46","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3390\/v14071575","article-title":"SARS-CoV-2 specific immune response and inflammatory profile in advanced HIV-Infected persons during a COVID-19 outbreak","volume":"14","author":"Vergori","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2026.01.003_bib47","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in Southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.01.003_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70036","article-title":"BIC\/FTC\/TAF benefits people living with HIV after Omicron breakthrough infection in shortening duration of symptoms, enhancing specific immune response and increasing total CD4 cells","volume":"96","author":"Wang","year":"2024","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virs.2026.01.003_bib49","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1097\/CM9.0000000000003176","article-title":"Severe acute respiratory syndrome coronavirus 2-specific T-cell responses are induced in people living with human immunodeficiency virus after booster vaccination","volume":"137","author":"Wang","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.virs.2026.01.003_bib50","series-title":"COVID-19 Cases","year":"2025"},{"key":"10.1016\/j.virs.2026.01.003_bib51","article-title":"Are older adults living with HIV more susceptible to omicron infection compared to their HIV-negative peers in China: a cross-sectional study","volume":"13","author":"Yang","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.virs.2026.01.003_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28428","article-title":"Booster shot of inactivated SARS-CoV-2 vaccine induces potent immune responses in people living with HIV","volume":"95","author":"Zhan","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virs.2026.01.003_bib53","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00688-25","article-title":"Inadequate immune response to inactivated COVID-19 vaccine among older people living with HIV: a prospective cohort study","volume":"99","author":"Zhang","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.01.003_bib54","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/vaccines11040789","article-title":"Correlation between CD4 T-Cell counts and seroconversion among COVID-19 vaccinated patients with HIV: a meta-analysis","volume":"11","author":"Zhou","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virs.2026.01.003_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.988304","article-title":"Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV","volume":"13","author":"Zou","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X2600009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X2600009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:29:47Z","timestamp":1776166187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X2600009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1995820X2600009X"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2026.01.003","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of humoral and T-cell immune responses in people living with HIV after breakthrough SARS-CoV-2 Omicron variant infection during December 2022 to January 2023","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2026.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}